This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Web of Science (1) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Zakynthinos, E. Articles by Papadogiannis, D. Search for Related Content PubMed PubMed Citation Articles by Zakynthinos, E. Articles by Papadogiannis, D. Social Bookmarking                         What's this?

Losartan Controlled Blood Pressure and Reduced Left Ventricular Hypertrophy But Did Not Alter Arrhythmias in Hypertensive Men with Preserved Systolic Function

Department of Critical Care, University of Athens Medical School, Athens, ezakynth{at}yahoo.com

Ch. Pierrutsakos, MD

Athinaion B’ Hospital, Athens

Z. Daniil, MD

Department of Critical Care, University of Athens Medical School, Athens

D. Papadogiannis, MD

Hypertensive Unit, 1st Department of Propedeutic Medicine, University of Athens Medical School, Athens, Greece

The effect of antihypertensive therapy on arrhythmias is controversial. An initial study in patients with chronic heart failure indicated that losartan, an angiotensin II receptor antagonist, may possess antiarrhythmic properties. However, the effect of AT1 receptor antagonists on arrhythmias of subjects with good systolic function has never been evaluated. Thirty-nine men with primary hypertension (18 without left ventricular hypertrophy [LVH], and 21 with LVH, aged 48.2 ±8.6 and 50.5 ±6.0 years, respectively), 15 healthy normotensive subjects (47.9 ±8.5 years), and 14 highly trained athletes (34.1 ±1.6 years) were studied. Transthoracic echocardiography and 24-hour Holter ambulatory monitoring were performed at baseline (without treatment). Hypertensive patients underwent the same examinations after 8 months of losartan administration. The prevalence and complexity of ventricular arrhythmias, and the frequency of supraventricular arrhythmias were increased in hypertensive patients with LVH compared to normotensive controls and athletes, at baseline. A similar significant reduction of blood pressure (BP) was noted in both groups of patients (p<0.001). The LVH was reduced in hypertensives with LVH (the left ventricular mass index by 12%, the interventricular septum by 8.1%, the posterior wall by 7%, all p<0.01). However, the arrhythmias did not change in either group of patients, even if all hypertensives were considered as 1 group. In conclusion, an 8-month course with losartan was effective in lowering BP and reducing LVH. However, the increased arrhythmias, which were registered in hypertensive patients with LVH at baseline, did not change.

Angiology, Vol. 56, No. 4, 439-449 (2005)
DOI: 10.1177/000331970505600412


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?